We are live on
!
Find out more
BI
Boulegeris Investments Portfolio holdings
AUM
$200M
1-Year Est. Return
7%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
+$9.96M
(+6%)
Cap. Flow
+$3.69M
Cap. Flow
% of AUM
2.09%
Top 10 Holdings %
Top 10 Hldgs %
73.73%
Holding
54
New
2
Increased
33
Reduced
10
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$924K |
| 2 |
RTN
Raytheon Company
RTN
|
+$763K |
| 3 |
CBL
CBL& Associates Properties, Inc.
CBL
|
+$661K |
| 4 |
MNR
Monmouth Real Estate Investment Corp
MNR
|
+$569K |
| 5 |
AGN
Allergan plc
AGN
|
+$499K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.4M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.11M |
| 3 |
Walt Disney
DIS
|
+$376K |
| 4 |
Apple
AAPL
|
+$374K |
| 5 |
NNN REIT
NNN
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 42.01% |
| 2 | Healthcare | 16.47% |
| 3 | Consumer Staples | 8.62% |
| 4 | Technology | 5.88% |
| 5 | Consumer Discretionary | 5.32% |
Similar funds
ACM
SSM
PCM
OA
XGI
MGA
MFP
ESG
Boulegeris Investments's Q2 2017 Portfolio in Review
As of Q2 2017, Boulegeris Investments held 54 positions worth $177M, up 6% from $167M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Boulegeris Investments's Q2 2017 filing shows 2 new, 33 increased, 10 reduced and 2 closed positions. Its largest new stake was CBL& Associates Properties, Inc.: 77,025 shares worth $649K. The largest sale was Gilead Sciences, an estimated $1.4M.
By sector, the portfolio is most concentrated in Real Estate at 42% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Staples.
- Boulegeris Investments's largest Q2 2017 buy was CBL& Associates Properties, Inc.: 77,025 shares worth $649K.
- Boulegeris Investments added most to Johnson & Johnson in Q2 2017, an estimated $924K increase.
- Boulegeris Investments's biggest Q2 2017 reduction was Walt Disney, cutting an estimated $376K.
- Boulegeris Investments fully exited Gilead Sciences in Q2 2017, selling an estimated $1.4M.
- Boulegeris Investments's ten largest holdings make up 74% of its $177M portfolio in Q2 2017.
- Boulegeris Investments opened 2 new positions and closed 2 in Q2 2017.
- Boulegeris Investments's portfolio value rose 6% quarter-over-quarter to $177M.
Based on Boulegeris Investments's 13F filing for Q2 2017, filed 8 Aug 2017.